VUS:CA:TSX-Vanguard US Total Market (CAD Hedged) (CAD)

ETF | US Equity |

Last Closing

CAD 99.55

Change

-0.92 (-0.92)%

Market Cap

CAD 1.05B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-1.54 (-1.12%)

CAD 17.23B
ZSP:CA BMO S&P 500

-0.96 (-1.13%)

CAD 16.16B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.51 (-0.85%)

CAD 10.90B
VUN:CA Vanguard US Total Market

-1.29 (-1.24%)

CAD 9.56B
XUS:CA iShares Core S&P 500 Index ETF

-0.56 (-1.16%)

CAD 7.36B
HXS:CA Global X S&P 500 Corporate Cla..

-0.95 (-1.19%)

CAD 4.06B
VSP:CA Vanguard S&P 500 CAD hedged

-0.84 (-0.90%)

CAD 3.52B
QUU:CA Mackenzie US Large Cap Equity ..

-2.53 (-1.13%)

CAD 3.25B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.64 (-1.27%)

CAD 3.07B
XUU:CA iShares Core S&P US Total Mark..

-0.71 (-1.24%)

CAD 3.07B

ETFs Containing VUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.31% 41% F 71% C-
Dividend Return 0.88% 34% F 26% F
Total Return 18.19% 41% F 69% C-
Trailing 12 Months  
Capital Gain 32.73% 62% D 79% B-
Dividend Return 1.33% 33% F 28% F
Total Return 34.06% 67% D+ 78% C+
Trailing 5 Years  
Capital Gain 79.11% 50% F 80% B-
Dividend Return 5.88% 27% F 20% F
Total Return 84.99% 55% F 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.72% N/A N/A 77% C+
Dividend Return 13.61% N/A N/A 75% C
Total Return 0.89% N/A N/A 34% F
Risk Return Profile  
Volatility (Standard Deviation) 19.68% N/A N/A 68% D+
Risk Adjusted Return 69.14% N/A N/A 83% B
Market Capitalization 1.05B 69% C- 69% C-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.